175 related articles for article (PubMed ID: 34707174)
1. High accumulation of Mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells.
Ren Y; Chen M; Wu G; Ji D; Zhou GG; Ren PG; Fu W
Sci Rep; 2021 Oct; 11(1):21227. PubMed ID: 34707174
[TBL] [Abstract][Full Text] [Related]
2. Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
Peters C; Paget M; Tshilenge KT; Saha D; Antoszczyk S; Baars A; Frost T; Martuza RL; Wakimoto H; Rabkin SD
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793956
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation promotes oncolytic HSV1 replication in glioma cells.
Okemoto K; Wagner B; Meisen H; Haseley A; Kaur B; Chiocca EA
PLoS One; 2013; 8(8):e71932. PubMed ID: 23936533
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.
Lee TJ; Nair M; Banasavadi-Siddegowda Y; Liu J; Nallanagulagari T; Jaime-Ramirez AC; Guo JY; Quadri H; Zhang J; Bockhorst KH; Aghi MK; Carbonell WS; Kaur B; Yoo JY
Mol Cancer Ther; 2019 Jun; 18(6):1127-1136. PubMed ID: 30926634
[TBL] [Abstract][Full Text] [Related]
5. Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors.
Hong B; Sahu U; Mullarkey MP; Kaur B
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062322
[TBL] [Abstract][Full Text] [Related]
6. PKR induces TGF-β and limits oncolytic immune therapy.
Hong B; Sahu U; Mullarkey MP; Hong E; Pei G; Yan Y; Otani Y; Banasavadi-Siddegowda Y; Fan H; Zhao Z; Yu J; Caligiuri MA; Kaur B
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36796878
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy.
Ghonime MG; Cassady KA
Cancer Immunol Res; 2018 Dec; 6(12):1499-1510. PubMed ID: 30352799
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
Friedman GK; Bernstock JD; Chen D; Nan L; Moore BP; Kelly VM; Youngblood SL; Langford CP; Han X; Ring EK; Beierle EA; Gillespie GY; Markert JM
Sci Rep; 2018 Sep; 8(1):13930. PubMed ID: 30224769
[TBL] [Abstract][Full Text] [Related]
9. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
Nakashima H; Kaufmann JK; Wang PY; Nguyen T; Speranza MC; Kasai K; Okemoto K; Otsuki A; Nakano I; Fernandez S; Goins WF; Grandi P; Glorioso JC; Lawler S; Cripe TP; Chiocca EA
J Clin Invest; 2015 Nov; 125(11):4269-80. PubMed ID: 26524593
[TBL] [Abstract][Full Text] [Related]
11. Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.
Zhang W; Fulci G; Wakimoto H; Cheema TA; Buhrman JS; Jeyaretna DS; Stemmer Rachamimov AO; Rabkin SD; Martuza RL
Neoplasia; 2013 Jun; 15(6):591-9. PubMed ID: 23730207
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3.
Delwar ZM; Kuo Y; Wen YH; Rennie PS; Jia W
Cancer Res; 2018 Feb; 78(3):718-730. PubMed ID: 29118089
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses.
Alayo QA; Ito H; Passaro C; Zdioruk M; Mahmoud AB; Grauwet K; Zhang X; Lawler SE; Reardon DA; Goins WF; Fernandez S; Chiocca EA; Nakashima H
Sci Rep; 2020 Mar; 10(1):5095. PubMed ID: 32198420
[TBL] [Abstract][Full Text] [Related]
15. USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells.
Lu R; Wu G; Chen M; Ji D; Liu Y; Zhou GG; Fu W
Mol Ther Oncolytics; 2021 Dec; 23():477-487. PubMed ID: 34901390
[TBL] [Abstract][Full Text] [Related]
16. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
17. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
[TBL] [Abstract][Full Text] [Related]
18. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy.
Ning J; Wakimoto H
Front Microbiol; 2014; 5():303. PubMed ID: 24999342
[TBL] [Abstract][Full Text] [Related]
20. TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response.
Han J; Chen X; Chu J; Xu B; Meisen WH; Chen L; Zhang L; Zhang J; He X; Wang QE; Chiocca EA; Kaur B; Caligiuri MA; Yu J
Cancer Res; 2015 Dec; 75(24):5273-82. PubMed ID: 26631269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
